Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDC25A | P30304 | 11/20 | 0.51 |
| ▸ | CDC25B | P30305 | 10/20 | 0.51 |
| ▸ | EBP | Q15125 | 5/20 | 0.50 |
| ▸ | NPC1L1 | Q9UHC9 | 2/20 | 0.44 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | USP2 | O75604 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29410405 | 1.00 | CDC25A (0.51) | CDC25ACDC25BEBPNPC1L1PTPN1 | |
| SCHEMBL29398347 | 1.00 | CDC25A (0.51) | CDC25ACDC25BEBPNPC1L1PTPN1 | |
| SCHEMBL29527487 | 1.00 | CDC25A (0.51) | CDC25ACDC25BEBPNPC1L1PTPN1 | |
| SCHEMBL14116734 | 0.87 | CDC25A (0.54) | CDC25ACDC25BEBPNPC1L1PTPN1 | |
| SCHEMBL14034589 | 0.87 | CDC25A (0.54) | CDC25ACDC25BEBPNPC1L1PTPN1 | |
| SCHEMBL28161748 | 0.85 | PTPN1 (0.44) | CDC25ACDC25BEBPNPC1L1PTPN1 | |
| SCHEMBL29364678 | 0.83 | CDC25A (0.50) | CDC25ACDC25BEBP | |
| SCHEMBL1470722 | 0.83 | EBP (0.48) | CDC25ACDC25BEBPNPC1L1MEN1 | |
| SCHEMBL1470720 | 0.83 | EBP (0.48) | CDC25ACDC25BEBPNPC1L1MEN1 | |
| SCHEMBL1470719 | 0.83 | EBP (0.48) | CDC25ACDC25BEBPNPC1L1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 106 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11851602-B2 | Epoxide and fluorinated epoxide stabilizers for fluoroolefins | THE CHEMOURS COMPANY FC, LLC (US) | 2023-12-26 | — | — | US | disclosed |
| US-20210380859-A1 | EPOXIDE AND FLUORINATED EPOXIDE STABILIZERS FOR FLUOROOLEFINS | THE CHEMOURS COMPANY FC, LLC (US) | 2021-12-09 | — | — | US | disclosed |
| US-20210355360-A1 | COMPOSITIONS COMPRISING FLUOROOLEFINS AND USES THEREOF | THE CHEMOURS COMPANY FC, LLC (US) | 2021-11-18 | — | — | US | disclosed |
| US-11130894-B2 | Epoxide and fluorinated epoxide stabilizers for fluoroolefins | THE CHEMOURS COMPANY FC, LLC (US) | 2021-09-28 | — | — | US | disclosed |
| US-11124685-B2 | Compositions comprising fluoroolefins and uses thereof | THE CHEMOURS COMPANY FC, LLC (US) | 2021-09-21 | — | — | US | disclosed |
| US-20210207014-A1 | COMPOSITIONS COMPRISING FLUOROOLEFINS AND USES THEREOF | THE CHEMOURS COMPANY FC, LLC (US) | 2021-07-08 | — | — | US | disclosed |
| US-11046877-B1 | Compositions comprising fluoroolefins and uses thereof | THE CHEMOURS COMPANY FC, LLC (US) | 2021-06-29 | — | — | US | disclosed |
| US-11046876-B2 | Compositions comprising fluoroolefins and uses thereof | THE CHEMOURS COMPANY FC, LLC (US) | 2021-06-29 | — | — | US | disclosed |
| US-20200339853-A1 | COMPOSITIONS COMPRISING FLUOROOLEFINS AND USES THEREOF | THE CHEMOURS COMPANY FC, LLC (US) | 2020-10-29 | — | — | US | disclosed |
| EP-3216840-B1 | COMPOSITIONS COMPRISING 1,1,1,4,4,4-HEXAFLUORO-2-BUTENE AND USES THEREOF | CHEMOURS CO FC LLC (US) | 2020-09-02 | — | — | EP | disclosed |
| WO-2008027515-A2 | PHOSPHORUS-CONTAINING STABILIZERS FOR FLUOROOLEFINS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2008-03-06 | — | — | WO | disclosed |
| WO-2008027511-A1 | EPOXIDE AND FLUORINATED EPOXIDE STABILIZERS FOR FLUOROOLEFINS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2008-03-06 | — | — | WO | disclosed |
| WO-2008027595-A1 | ALKYL SILANE STABILIZERS FOR FLUOROOLEFINS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2008-03-06 | — | — | WO | disclosed |
| WO-2008027594-A2 | PHENOL STABILIZERS FOR FLUOROOLEFINS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2008-03-06 | — | — | WO | disclosed |
| WO-2008027512-A2 | FUNCTIONALIZED PERFLUOROPOLYETHER STABILIZERS FOR FLUOROOLEFINS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2008-03-06 | — | — | WO | disclosed |
| WO-2008027596-A2 | BENZOPHENONE DERIVATIVE STABILIZERS FOR FLUOROOLEFINS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2008-03-06 | — | — | WO | disclosed |
| WO-2008027519-A1 | OXETANE STABILIZERS FOR FLUOROOLEFINS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2008-03-06 | — | — | WO | disclosed |
| WO-2008027517-A1 | THIOL AND THIOETHER STABILIZERS FOR FLUOROOLEFINS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2008-03-06 | — | — | WO | disclosed |
| WO-2007126760-A2 | COMPOSITIONS COMPRISING IODOTRIFLUOROMETHANE AND STABILIZERS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2007-11-08 | — | — | WO | disclosed |
| US-20070108403-A1 | refrigerants as heat exchanger; comprising 1,1,1,4,4,5,5,5-octafluoro-2-pentene mixture | E. I. DU PONT DE NEMOURS AND COMPANY | 2007-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210355360-A1 | COMPOSITIONS COMPRISING FLUOROOLEFINS AND USES THEREOF | GFPT1, PFAS, TRMT1 | CDC25A 3418/4885CDC25B 3503/4885EBP 2830/4885 |
| US-20200339853-A1 | COMPOSITIONS COMPRISING FLUOROOLEFINS AND USES THEREOF | GFPT1, PFAS, TRMT1 | CDC25A 3418/4885CDC25B 3503/4885EBP 2830/4885 |
| US-11046876-B2 | Compositions comprising fluoroolefins and uses thereof | GFPT1, PFAS, TRMT1 | CDC25A 3418/4885CDC25B 3503/4885EBP 2830/4885 |
| US-11046877-B1 | Compositions comprising fluoroolefins and uses thereof | GFPT1, PFAS, TRMT1 | CDC25A 3418/4885CDC25B 3503/4885EBP 2830/4885 |
| US-20210207014-A1 | COMPOSITIONS COMPRISING FLUOROOLEFINS AND USES THEREOF | GFPT1, PFAS, TRMT1 | CDC25A 3418/4885CDC25B 3503/4885EBP 2830/4885 |
| US-11124685-B2 | Compositions comprising fluoroolefins and uses thereof | GFPT1, PFAS, TRMT1 | CDC25A 3418/4885CDC25B 3503/4885EBP 2830/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.